Biofrontera Inc.

DB:AI10 Stock Report

Market Cap: €11.3m

Biofrontera Management

Management criteria checks 0/4

Biofrontera's CEO is Hermann Luebbert, appointed in May 2023, has a tenure of less than a year. total yearly compensation is $1.28M, comprised of 37.1% salary and 62.9% bonuses, including company stock and options. directly owns 0.76% of the company’s shares, worth €86.61K. The average tenure of the management team and the board of directors is 0.9 years and 1.9 years respectively.

Key information

Hermann Luebbert

Chief executive officer

US$1.3m

Total compensation

CEO salary percentage37.1%
CEO tenureless than a year
CEO ownership0.8%
Management average tenureless than a year
Board average tenure1.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Hermann Luebbert's remuneration changed compared to Biofrontera's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2023n/an/a

-US$23m

Mar 31 2023n/an/a

-US$14m

Dec 31 2022US$1mUS$475k

-US$640k

Sep 30 2022n/an/a

-US$12m

Jun 30 2022n/an/a

-US$26m

Mar 31 2022n/an/a

-US$29m

Dec 31 2021US$1mUS$18k

-US$38m

Compensation vs Market: Hermann's total compensation ($USD1.28M) is above average for companies of similar size in the German market ($USD418.12K).

Compensation vs Earnings: Hermann's compensation has increased whilst the company is unprofitable.

CEO

Hermann Luebbert (67 yo)

less than a year

Tenure

US$1,278,232

Compensation

Dr. Prof. Hermann Luebbert, Ph.D. is a Co-Founder of Biofrontera AG and served as its Chief Executive Officer since 1997 until December 13, 2021 and served as its Chairman of Management Board since 2000 un...

Leadership Team

NamePositionTenureCompensationOwnership
Hermann Luebbert
Chairmanless than a yearUS$1.28m0.76%
€ 86.6k
Eugene Leffler
Chief Financial Officerless than a yearUS$316.32kno data
Erica Gates
Senior Director of Finance & Principal Accounting Officerno datano datano data
Jon Lyons
Vice President of Scientific & Medical Affairsless than a yearno datano data
Alycia Torres
Vice President of Administration1.8yrsno datano data
Daniel Hakansson
General Counsel & Head of Compliance4.8yrsno datano data
Samantha Widdicombe
Senior Director of Strategic Accounts & Communicationsless than a yearno datano data
Mark Baldyga
Vice President of & Marketingno datano datano data
Anthony Takazawa
Executive Officerno datano datano data

0.9yrs

Average Tenure

Experienced Management: AI10's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Hermann Luebbert
Chairman8.6yrsUS$1.28m0.76%
€ 86.6k
John Borer
Director1.9yrsUS$93.55kno data
Heikki Lanckriet
Directorless than a yearno datano data
Kevin Weber
Director1.6yrsUS$79.53kno data
Beth Hoffman
Independent Director1.9yrsUS$93.04kno data

1.9yrs

Average Tenure

66yo

Average Age

Experienced Board: AI10's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/10/01 05:45
End of Day Share Price 2023/07/04 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biofrontera Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bruce JacksonBenchmark Company
Jonathan AschoffRoth MKM